Circulating tumor DNA (ctDNA) as predictive biomarker in NSCLC patients treated with nivolumab
Gespeichert in:
Veröffentlicht in: | Annals of oncology 2017-04, Vol.28, p.ii10-ii11 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | ii11 |
---|---|
container_issue | |
container_start_page | ii10 |
container_title | Annals of oncology |
container_volume | 28 |
creator | Passiglia, F. Perez, A. Listì, A. Castiglia, M. Musso, E. Ancona, C. Rizzo, S. Alù, M. Blasi, L. Russo, A. |
description | |
doi_str_mv | 10.1093/annonc/mdx089.007 |
format | Article |
fullrecord | <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdx089_007</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1093_annonc_mdx089_007</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1337-194139370ff9289ab9ee92687a7226aaac49a22940aaabc6756e72bbb36f97213</originalsourceid><addsrcrecordid>eNotkL1OwzAYRT2ARCk8AJtHGNL6J43zjVX4laoyACvRZ8cBQ-JEtlvg7Qkq07nLvbo6hFxwtuAM5BK9H7xZ9s03K2HBmDoiMwZCZmol8xNyGuMHY6wAATPyWrlgdh0m599o2vVDoNfbNb00acIVxUjHYBtnkttbqt3QY_i0gTpPt0_VpqLj1LQ-RZqCxWQb-uXSO_VuP3S7HvUZOW6xi_b8n3PycnvzXN1nm8e7h2q9yQyXUmUcci5BKta2IEpADdaCKEqFSogCEU0OKATkbMraFGpVWCW01rJoQQku54Qfdk0YYgy2rcfgpq8_NWf1n5T6IKU-SKknKfIXnYVZ2w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Circulating tumor DNA (ctDNA) as predictive biomarker in NSCLC patients treated with nivolumab</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Passiglia, F. ; Perez, A. ; Listì, A. ; Castiglia, M. ; Musso, E. ; Ancona, C. ; Rizzo, S. ; Alù, M. ; Blasi, L. ; Russo, A.</creator><creatorcontrib>Passiglia, F. ; Perez, A. ; Listì, A. ; Castiglia, M. ; Musso, E. ; Ancona, C. ; Rizzo, S. ; Alù, M. ; Blasi, L. ; Russo, A.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>DOI: 10.1093/annonc/mdx089.007</identifier><language>eng</language><ispartof>Annals of oncology, 2017-04, Vol.28, p.ii10-ii11</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1337-194139370ff9289ab9ee92687a7226aaac49a22940aaabc6756e72bbb36f97213</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Passiglia, F.</creatorcontrib><creatorcontrib>Perez, A.</creatorcontrib><creatorcontrib>Listì, A.</creatorcontrib><creatorcontrib>Castiglia, M.</creatorcontrib><creatorcontrib>Musso, E.</creatorcontrib><creatorcontrib>Ancona, C.</creatorcontrib><creatorcontrib>Rizzo, S.</creatorcontrib><creatorcontrib>Alù, M.</creatorcontrib><creatorcontrib>Blasi, L.</creatorcontrib><creatorcontrib>Russo, A.</creatorcontrib><title>Circulating tumor DNA (ctDNA) as predictive biomarker in NSCLC patients treated with nivolumab</title><title>Annals of oncology</title><issn>0923-7534</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNotkL1OwzAYRT2ARCk8AJtHGNL6J43zjVX4laoyACvRZ8cBQ-JEtlvg7Qkq07nLvbo6hFxwtuAM5BK9H7xZ9s03K2HBmDoiMwZCZmol8xNyGuMHY6wAATPyWrlgdh0m599o2vVDoNfbNb00acIVxUjHYBtnkttbqt3QY_i0gTpPt0_VpqLj1LQ-RZqCxWQb-uXSO_VuP3S7HvUZOW6xi_b8n3PycnvzXN1nm8e7h2q9yQyXUmUcci5BKta2IEpADdaCKEqFSogCEU0OKATkbMraFGpVWCW01rJoQQku54Qfdk0YYgy2rcfgpq8_NWf1n5T6IKU-SKknKfIXnYVZ2w</recordid><startdate>201704</startdate><enddate>201704</enddate><creator>Passiglia, F.</creator><creator>Perez, A.</creator><creator>Listì, A.</creator><creator>Castiglia, M.</creator><creator>Musso, E.</creator><creator>Ancona, C.</creator><creator>Rizzo, S.</creator><creator>Alù, M.</creator><creator>Blasi, L.</creator><creator>Russo, A.</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201704</creationdate><title>Circulating tumor DNA (ctDNA) as predictive biomarker in NSCLC patients treated with nivolumab</title><author>Passiglia, F. ; Perez, A. ; Listì, A. ; Castiglia, M. ; Musso, E. ; Ancona, C. ; Rizzo, S. ; Alù, M. ; Blasi, L. ; Russo, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1337-194139370ff9289ab9ee92687a7226aaac49a22940aaabc6756e72bbb36f97213</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Passiglia, F.</creatorcontrib><creatorcontrib>Perez, A.</creatorcontrib><creatorcontrib>Listì, A.</creatorcontrib><creatorcontrib>Castiglia, M.</creatorcontrib><creatorcontrib>Musso, E.</creatorcontrib><creatorcontrib>Ancona, C.</creatorcontrib><creatorcontrib>Rizzo, S.</creatorcontrib><creatorcontrib>Alù, M.</creatorcontrib><creatorcontrib>Blasi, L.</creatorcontrib><creatorcontrib>Russo, A.</creatorcontrib><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Passiglia, F.</au><au>Perez, A.</au><au>Listì, A.</au><au>Castiglia, M.</au><au>Musso, E.</au><au>Ancona, C.</au><au>Rizzo, S.</au><au>Alù, M.</au><au>Blasi, L.</au><au>Russo, A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Circulating tumor DNA (ctDNA) as predictive biomarker in NSCLC patients treated with nivolumab</atitle><jtitle>Annals of oncology</jtitle><date>2017-04</date><risdate>2017</risdate><volume>28</volume><spage>ii10</spage><epage>ii11</epage><pages>ii10-ii11</pages><issn>0923-7534</issn><doi>10.1093/annonc/mdx089.007</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0923-7534 |
ispartof | Annals of oncology, 2017-04, Vol.28, p.ii10-ii11 |
issn | 0923-7534 |
language | eng |
recordid | cdi_crossref_primary_10_1093_annonc_mdx089_007 |
source | EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
title | Circulating tumor DNA (ctDNA) as predictive biomarker in NSCLC patients treated with nivolumab |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T16%3A21%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Circulating%20tumor%20DNA%20(ctDNA)%20as%20predictive%20biomarker%20in%20NSCLC%20patients%20treated%20with%20nivolumab&rft.jtitle=Annals%20of%20oncology&rft.au=Passiglia,%20F.&rft.date=2017-04&rft.volume=28&rft.spage=ii10&rft.epage=ii11&rft.pages=ii10-ii11&rft.issn=0923-7534&rft_id=info:doi/10.1093/annonc/mdx089.007&rft_dat=%3Ccrossref%3E10_1093_annonc_mdx089_007%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |